Medtronic (MDT) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $117.88B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | IE | CEO | Geoffrey Straub Martha |
| IPO Date | 1973-05-02 | CAGR | 11.92% |
| Employees | 95,000 | Website | www.medtronic.com |
| Div. Yield | 0.15% | Payout Ratio | 76% |
| Buy Back Yield | 0.04% | Total Yield | 0.19% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $124.58B | P/E | 16.65 | Forward P/E | 14.13 | PEG | 1.33 |
| P/S | 64.36 | P/B | 47.73 | P/CF | 319.06 | P/FCF | 430.56 |
| Sales | $36.36B | Sales 1Y | 8.43% | Sales 3Y | 16.45% | Sales 5Y | 20.74% |
| EPS | $5.53 | EPS 1Y | 3.04% | EPS 3Y | 32.27% | EPS 5Y | 40.23% |
| Sales QoQ | 8.75% | EPS QoQ | 7.87% | Sales QoQ Avg | 2.49% | EPS QoQ Avg | 5.48% |
| Gross Margin | 44.56% | Operating Margin | 18.63% | Profit Margin | 13.2% | ROCE | 8.26% |
| ROA | 5% | ROE | 10% | Altman Z Score | 3 | Piotroski Score | 5 |
| Current Ratio | 2.54 | Quick Ratio | 2.62 | Cash Ratio | 0.12 | Op. CF Ratio | 0.29 |
| Debt/Equity | 0.57 | Debt/Assets | 0.31 | Lt Debt/Equity | 0.57 | Lt Debt/Cap. | 0.36 |
| Intrst Cov. | 9.49 | Inventory Turnover | -12.89 | Asset Turnover | 0.4 | Receivables Turnover | 417.98 |
| Enterprise Value | $124.58B | P/E Ratio | 16.65 |
| Forward P/E | 14.13 | PEG Ratio | 1.33 |
| P/S Ratio | 64.36 | P/B Ratio | 47.73 |
| P/CF Ratio | 319.06 | P/FCF Ratio | 430.56 |
| EPS | $5.53 | EPS Growth 1Y | 3.04% |
| EPS Growth 3Y | 32.27% | EPS Growth 5Y | 40.23% |
| Revenue Growth 1Y | 8.43% | Gross Margin | 0.45% |
| Operating Margin | 0.19% | Profit Margin | 0.13% |
| ROE | 0.1% | ROA | 0.05% |
| ROCE | 0.08% | Current Ratio | 2.54 |
| Quick Ratio | 2.62 | Cash Ratio | 0.12 |
| Debt/Equity | 0.57 | Interest Coverage | 9.49 |
| Altman Z Score | 3 | Piotroski Score | 5 |
Medtronic (MDT) valuation & financials
Medtronic (MDT) has a market capitalization of $117.88B and trades at a price-to-earnings ratio of 16.6. It operates in the Healthcare sector (Medical - Devices).
Medtronic's revenue grew +8.4% over the last year.
Medtronic's next earnings report is scheduled for September 1, 2026 before market open; analysts estimate EPS of $1.39. Check the earnings calendar to see all companies reporting this week.
Medtronic (MDT) — frequently asked questions
When does Medtronic (MDT) report earnings next?
Medtronic is expected to report earnings on September 1, 2026 before market open. Analysts estimate EPS of $1.39.
What is Medtronic's market cap?
Medtronic (MDT) has a market capitalization of $117.88B.
What is MDT's P/E ratio?
Medtronic trades at a price-to-earnings ratio of 16.6, with trailing twelve-month EPS of $5.53.
How fast is Medtronic growing?
Medtronic's revenue grew +8.4% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)